Beryl Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Beryl Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,339,518	Closed	-$210M	–	44
2023 Q2	$210M	Buy	+5,339,518	New	+$188M	52.85%	1

Beryl Capital Management's ISEE Position: Q3 2023 in Review

Beryl Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 5,339,518 shares — an estimated $210M sold.

Beryl Capital Management first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $210M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Beryl Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Beryl Capital Management sold 5,339,518 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $210M.
Beryl Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Beryl Capital Management's IVERIC bio, Inc. Common Stock position peaked at $210M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Beryl Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.